CAPORALI, R.; RAVASIO, R.; RAIMONDO, P.; SALAFFI, F. Erratum in: Cost per responder for upadacitinib vs abatacept in patients with moderate-to-severe Rheumatoid Arthritis in Italy. Global & Regional Health Technology Assessment, [S. l.], v. 9, n. 1, p. 30, 2022. DOI: 10.33393/grhta.2022.2383. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/2383. Acesso em: 15 aug. 2022.